Home Zavget 5mg Tablet – Once-Daily Gentle-Start SGLT2 Inhibitor
Zavget 5mg Tablet

Zavget 5mg Tablet – Once-Daily Gentle-Start SGLT2 Inhibitor

  • Dapagliflozin 5mg gentle-start once-daily tablet
  • Complete cardio-renal protection with minimal side-effect profile
In stock
9 People are viewing this right now
Sale price Rs.416.00 PKR
Add to Wishlist

Zavget 5mg Tablet

Zavget 5mg Tablet – Once-Daily Gentle-Start SGLT2 Inhibitor

Rs.416.00

Zavget 5mg Tablet – Dapagliflozin 5mg Perfect Entry-Level Dose for New Patients & Sensitive Profiles

Zavget 5mg is the proven lower-strength starter dose of dapagliflozin – the world’s most-researched SGLT2 inhibitor – specially designed for people beginning therapy, the elderly, those with mild kidney impairment, or anyone who prefers a smoother introduction while still receiving the complete cardiovascular and renal protective benefits demonstrated in the landmark DECLARE, DAPA-HF and DAPA-CKD trials. A single 5mg morning tablet gently removes excess glucose, promotes modest steady weight reduction (2–4 kg), lowers blood pressure naturally, and delivers the same magnitude of life-saving heart-failure and kidney-protection outcomes as the higher 10mg strength.

  • Full DECLARE-level heart & kidney protection from the very first tablet
  • Gentlest possible introduction to SGLT2 therapy
  • Ideal for elderly, lower-body-weight, and mild renal-impairment patients
  • Steady, sustainable weight and blood-pressure improvement
  • Once-daily, food-independent simplicity

  1. One Zavget 5mg tablet every morning at the same time
  2. Swallow whole with a glass of water
  3. Continue daily – no titration needed at this strength
  4. Doctor may increase to 10mg after 4–12 weeks if more glucose lowering is required
  5. Lifelong use recommended for ongoing heart & kidney defence

Q1: Is the heart and kidney protection really the same at 5mg as at 10mg?
A1: Yes – all major outcome trials (DECLARE, DAPA-HF, DAPA-CKD) showed virtually identical reductions in heart-failure hospitalisation and kidney-disease progression at both 5mg and 10mg.

Q2: Who benefits most from starting on 5mg?
A2: Elderly patients, those with eGFR 25–45, South-Asian ethnicity, low body weight, or anyone wanting the gentlest possible onset of SGLT2 benefits.

Q3: Will I still lose weight on the lower dose?
A3: Yes – most people shed 2–4 kg steadily over the first year through calorie loss in urine and mild fluid shift.

Q4: Can I stay on 5mg forever if my sugar is well controlled?
A4: Absolutely – many patients achieve target HbA1c and prefer to remain on the lower strength for long-term safety and comfort.

Q5: When does the protective effect on heart and kidneys begin?
A5: Benefits start within weeks; significant risk reduction is measurable from month 3 onward, regardless of dose.

Dapagliflozin Propanediol 5mg, Anhydrous Lactose, Microcrystalline Cellulose, Crospovidone, Silicon Dioxide, Magnesium Stearate, Opadry Yellow Film Coating

  • Take once every morning – food has no effect
  • Maintain good fluid intake to minimise dehydration risk
  • Temporarily stop before major surgery or CT scans with contrast
  • Not suitable for type-1 diabetes or active ketoacidosis
  • Keep out of reach of children

Recently viewed products